Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01)

The summary for the Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01)
	CFDA Number:	93.279
	CFDA Description:	Drug Abuse and Addiction Research Programs
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PAS-09-001
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Oct 02, 2008
	Creation Date:	Oct 02, 2008
	Original Closing Date for Applications:	Jan 07, 2012
	Current Closing Date for Applications:	Jan 07, 2012
	Archive Date:	Feb 07, 2012
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: -Purpose. Through this program announcement with set aside (PAS), the National Institute on Drug Abuse (NIDA) invites applicants to develop innovative drug abuse epidemiology or health services research in cooperation with academic centers supported through the NIH Clinical and Translational Science Awards (CTSA) consortium. A major NIH initiative, the CTSA consortium is transforming how clinical and translational research is conducted, building an infrastructure for multidisciplinary researchers and clinicians to perform research and develop new treatments more efficiently. As a part of this infrastructure, CTSA sites have established partnerships with a range of clinical settings and have access to large, multi-generational population cohorts. These features of the CTSA sites offer a unique opportunity for researchers to integrate drug abuse epidemiology and health services research in these settings. Applicants are asked to propose innovative drug abuse research which builds upon the resources available at CTSA sites, resources which would include CTSA efforts to strengthen networks of clinical sites and to establish innovative information technologies, phenotyping systems, and biobanks. A broad range of drug abuse epidemiology and health services research areas will be supported under the auspices of this FOA, as described below. -Mechanism of Support. This FOA will utilize the R01 grant mechanism. -Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 4 to 8 projects awarded as a result of this announcement is $2 million for fiscal year 2009 and $2 million for fiscal year 2010. Future year amounts will depend on annual appropriations. The total amount awarded and the number of awards will depend upon the number, quality, duration, and cost of the applications received. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pas-09-001.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1); • Pre-Application for the FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (X02); • Pre-Application for the 2012 NIDA Translational Avant-Garde Award for Medication Development for the...; • 2012 NIDA Translational Avant-Garde Award for Medication Development for the Treatment of Substance ...; • International Tobacco and Health Research and Capacity Building Program (R01); • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • DRUG ABUSE ASPECTS OF HIV/AIDS AND OTHER INFECTIONS; • EPIDEMIOLOGY OF DRUG ABUSE; • PRESCRIPTION DRUG ABUSE; • MDMA: RESEARCH AREAS NEEDING MORE EMPHASIS